GABARAPL1 and triple-negative breast carcinoma: We then detected the expression level of GABARAPL1 in 20 TNBC tissues and their matched adjacent normal tissues (Normal-1), together with 20 non-triple-negative breast cancer (NTNBC) tissues and their matched adjacent normal tissues (Normal-2).